The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis

Bonnie Lam, Yuan Cai, Rufus Akinyemi, Geert Jan Biessels, Hilde van den Brink, Christopher Chen, Chin Wai Cheung, King Ngai Chow, Henry Kwun Hang Chung, Marco Duering, Siu Ting Fu, Deborah Gustafson, Saima Hilal, Vincent Ming Ho Hui, Raj N. Kalaria, SangYun Kim, Maggie Li Man Lam, Frank‐Erik de Leeuw, Ami Sin Man Li, Hugh S. Markus, Anna Marseglia, Huijing Zheng, John T. O’Brien, Leonardo Pantoni, Perminder S. Sachdev, Eric E. Smith, Joanna M. Wardlaw, Vincent MokInternational Journal of Stroke 2022 · DOI

Introduction

Cerebral small vessel disease (cSVD) is a "silent" but potent driver of stroke, dementia, and mobility issues. While the condition is well-documented in high-income countries (HICs), our understanding of its global footprint has historically been lopsided. Low- and middle-income countries (LMICs) face unique challenges, including distinct vascular risk profiles, varying healthcare infrastructure, and diverse genetic backgrounds, yet they have been largely excluded from large-scale systematic assessments.

This paper presents the first systematic review and meta-analysis of cSVD prevalence in LMICs, addressing this "data desert" by synthesizing research to estimate the true prevalence of neuroimaging markers such as white matter hyperintensities (WMH), lacunes, and microbleeds.

Methodology

The researchers conducted a rigorous systematic review of literature published between 2000 and 2022 across the Ovid MEDLINE and EMBASE databases. The analysis drew from 40 studies representing 48 independent cohorts and a total of 509,361 adults.

Key methodological features included:

  • Meta-analysis of Proportions: Used to pool the prevalence of specific cSVD markers across different health statuses (community-dwelling, stroke, and dementia).
  • Meta-regression: Employed to investigate how variables like age, sex (male-to-female ratio), and study type influenced prevalence rates.
  • Standardization: The team prioritized studies using the STRIVE (STandards for ReportIng Vascular changes on nEuroimaging) classifications to ensure consistency across disparate datasets.
  • Quality Assessment: Study quality was evaluated using the RoBANS tool for non-randomized studies.

Key Insights and Results

The Prevalence of cSVD Markers

The study provided concrete median prevalence rates for several key cSVD markers, demonstrating a significant health burden that scales with clinical severity:

  • White Matter Hyperintensities (WMH): Prevalence was recorded at 20.5% in the community, rising to 40.5% in stroke patients and 58.4% in dementia patients.
  • Lacunes: These were found in 0.8% of community participants but jumped to 25.6% in stroke cohorts.
  • Cerebral Microbleeds (CMB): Mean prevalence was 10.7% in the community and 24.1% in stroke groups.
  • Perivascular Spaces (PVS): Moderate-to-severe PVS were found in 25.0% of community-dwelling individuals.

The "Dementia Multiplier" and Age

A critical finding was that the prevalence of moderate-to-severe WMH nearly triples from community groups to dementia groups. This underscores cSVD's role as a major contributor to cognitive decline in LMICs. Furthermore, meta-regression confirmed that age is the most significant predictor for the prevalence of both WMH and lacunes, suggesting that the biological aging of the brain's vasculature follows a similar trajectory regardless of regional economic status.

The review highlighted a recent explosion in research; all included studies were published after 2010, indicating a surge in neuroimaging research capacity within LMICs. However, geographic distribution remains uneven. While 13 global regions were represented, there was a heavy concentration in China (n=23), and a total lack of published data from Central Europe, Eastern Europe, and Central Asia.

Limitations and Future Directions

The primary hurdle identified was high heterogeneity (>95%) between studies, likely driven by inconsistent MRI protocols (ranging from 0.2T to 3.0T field strengths) and varying visual rating scales. Additionally, male participants were significantly overrepresented (mean male:female ratio of 1.52), reflecting potential recruitment biases in hospital-based stroke trials.

Future Work Should Focus On: * Regional Diversity: There is an urgent need for data from Sub-Saharan Africa, Central/Eastern Europe, and Central Asia. * Methodological Harmony: Future studies should move toward 3.0T MRI and harmonized reporting methods (like STRIVE) to allow for direct comparisons between LMICs and HICs. * Population-Based Research: Increasing community-based studies will help move beyond the biases inherent in clinical "stroke-only" cohorts.

Conclusion

This systematic review demonstrates that cSVD is highly prevalent in LMICs and is a major contributor to the regional burden of stroke and dementia. While research interest is growing rapidly, addressing geographic gaps and standardizing imaging protocols will be essential for developing effective global health interventions.

Summary updated

Abstract

This systematic review and meta-analysis provide data on cSVD prevalence in LMICs and demonstrated the high prevalence of the condition. cSVD research in LMICs is being published at an increasing rate, especially between 2010 and 2022. More data are particularly needed from Sub-Saharan Africa and Central Europe, Eastern Europe, and Central Asia.
BibTeX
@article{lam2022global,
  author = {Bonnie Lam and Yuan Cai and Rufus Akinyemi and Geert Jan Biessels and Hilde van den Brink and Christopher Chen and Chin Wai Cheung and King Ngai Chow and Henry Kwun Hang Chung and Marco Duering and Siu Ting Fu and Deborah Gustafson and Saima Hilal and Vincent Ming Ho Hui and Raj N. Kalaria and SangYun Kim and Maggie Li Man Lam and Frank‐Erik de Leeuw and Ami Sin Man Li and Hugh S. Markus and Anna Marseglia and Huijing Zheng and John T. O’Brien and Leonardo Pantoni and Perminder S. Sachdev and Eric E. Smith and Joanna M. Wardlaw and Vincent Mok},
  title = {{The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis}},
  journal = {International Journal of Stroke},
  year = {2022},
  doi = {10.1177/17474930221137019},
}
Figure